MediaMedic

Professor SiZhou Feng : The Application of mNGS in Hematological Infections and the Optimization of Empirical Treatment Plans for Neutropenia-Associated Fever

By Yin, Jiale 2024.01.26

Editor's Note: At the recently held Fourth China Hematology Development Conference, the "Chinese Expert Consensus on the Application of Metagenomic Next-Generation Sequencing (mNGS) in the Diagnosis of Infectious Pathogens in…

Multidisciplinary Perspective: Professor MingGui Wang Shares Insights on the Application of mNGS in Blood Disease Infection Detection and Progress in Global CRO New Drug Treatment

By Yin, Jiale 2024.01.26

Editor's Note: In recent years, the problem of drug resistance has intensified, and carbapenem-resistant organisms (CRO), representing multiple drug-resistant bacteria, have imposed a significant disease burden globally. Patients with blood diseases…

Major Announcement! Top 10 Research Advances in Chinese Hematology in 2023 Revealed

By Yin, Jiale 2024.01.26

On January 7th, the Fourth Chinese Hematology Development Conference unveiled the "Top 10 Research Advances in Chinese Hematology in 2023." The selection of the "Top 10 Research Advances in Chinese…

2024 CASH | Professor ZhiJian Xiao : Breaking Through Tradition, Marching Towards the Future, The Perfect Integration of Precision Diagnosis and Digital Science

By Yin, Jiale 2024.01.26

The diagnosis of hematologic diseases has transitioned from traditional morphology-based methods to molecular diagnostics. Simultaneously, the treatment of these diseases has also moved from traditional chemotherapy to precision therapy, particularly…

2024 CASH | Professor XiaoFan Zhu : Immunotherapy Strategy Brings Greater Benefits to Children with ALL

By Yin, Jiale 2024.01.26

Children with Acute Lymphoblastic Leukemia (ALL) have a five-year overall survival (OS) rate exceeding 90%, but about 20% still experience disease relapse. Treating these relapsed or refractory ALL cases is…

2024 CASH丨Professor RongFu : Progress in the Study of Hematological Toxicity Related to CAR-T Therapy

By Yin, Jiale 2024.01.26

Immunotherapy has recently emerged as a focal area in the research of hematologic oncology. The advancement of genetic engineering and molecular biology, coupled with deeper insights into the mechanisms of…

2024 CASH | Professor LuGui Qiu : Continuous Advances in New Drugs, The Road to Cure Multiple Myeloma is Being Realized

By Yin, Jiale 2024.01.26

From January 5th to 7th, 2024, the Fourth China Hematology Development Conference (CASH) was grandly held in Tianjin. Continuing the theme of "Big Hematology, Big Health, Big Healthcare," the conference…

2024 CASH | Professor Lei Zhang : Gene Therapy Based on AAV Vector Brings Hope for Cure to Hemophilia Patients

By Yin, Jiale 2024.01.26

From January 5th to 7th, 2024, the 4th China/Academy of Hematology Sciences Development Conference (CASH) was grandly held in Tianjin. Continuing with the theme "Comprehensive Hematology, Healthcare, and Wellness", this…

2024 CASH丨Professor Jun Shi : Gene Therapy for β-Thalassemia Using Lentiviral Vectors

By Yin, Jiale 2024.01.26

β-thalassemia is a hereditary blood disorder caused by mutations in the β-globin gene, leading to impaired synthesis or structural changes in β-globin. Gene therapy for β-thalassemia using lentiviral vectors refers…

2024 CASH | Professor Jun Ma : From ASH to CASH, the Mission of Serving Patients and Strengthening Innovation Remains Unchanged

By Yin, Jiale 2024.01.26

Organized by the China Medical Science Academy Peking Union Medical College and co-hosted by the Hematology Hospital of the China Medical Science Academy (Institute of Hematology), the 4th Chinese Hematology…

Cultivating Virtue to Advance Surgery · Upholding the Way in Clinical Excellence | Xuesong Li’s Team Completes the First Fully Intracorporeal Autologous Kidney Transplant Using a Domestic Surgical Robot

Breast Cancer Chronicle · 2025 Professor Shusen Wang: Advances in Endocrine Therapy for HR+/HER2− Advanced Breast Cancer — Approval of Inavolisib-Based Combinations and New Pathways Opened by the evERA BC Study

Breast Cancer Chronicle · 2025 Professor Jin Yang: Breakthroughs from the ASCENT and TROPION Programs Signal the Dawn of Precision Therapy for Advanced Triple-Negative Breast Cancer

Latest Research from Academician Binghe Xu’s Team: Anucleate Red Blood Cells Act as Tumor DNA “Reservoirs,” with Apoptotic Bodies Identified as the Key Couriers

Professor Honghu Zhu: Advances, Evolution, and Future Directions of Hematopoietic Stem Cell Transplantation in Acute Leukemia丨2026 CSCO Academic Conference on Hematologic Malignancies

CASH 2026 Professor Wenbin Qian: Advancing Fourth-Generation CAR-T Therapy—Decoding Long-Term Efficacy, Resistance Mechanisms, and Future Directions

Annual Review Professor Bing Xu: Interpreting New Paradigms and Future Pathways in the Diagnosis and Treatment of Follicular Lymphoma

CASH 2026 Professor Jun Shi: New Insights into the Immune Mechanisms of Aplastic Anemia — Targeting CD38 and the JAK Pathway Shows Promising Therapeutic Potential

CASH 2026 Professor Erlie Jiang: Four Decades of Continuity and Innovation — The “Tianjin Model” Pioneering a New Era in Hematopoietic Stem Cell Transplantation

Lymphoma Roundtable · ASH Special Professor Qingqing Cai: New Advances in Bispecific Antibody Therapy for Relapsed/Refractory Lymphoma

Cultivating Virtue to Advance Surgery · Upholding the Way in Clinical Excellence | Xuesong Li’s Team Completes the First Fully Intracorporeal Autologous Kidney Transplant Using a Domestic Surgical Robot

Breast Cancer Chronicle · 2025 Professor Shusen Wang: Advances in Endocrine Therapy for HR+/HER2− Advanced Breast Cancer — Approval of Inavolisib-Based Combinations and New Pathways Opened by the evERA BC Study

Professor SiZhou Feng : The Application of mNGS in Hematological Infections and the Optimization of Empirical Treatment Plans for Neutropenia-Associated Fever

Multidisciplinary Perspective: Professor MingGui Wang Shares Insights on the Application of mNGS in Blood Disease Infection Detection and Progress in Global CRO New Drug Treatment

Major Announcement! Top 10 Research Advances in Chinese Hematology in 2023 Revealed

2024 CASH | Professor ZhiJian Xiao : Breaking Through Tradition, Marching Towards the Future, The Perfect Integration of Precision Diagnosis and Digital Science

2024 CASH | Professor XiaoFan Zhu : Immunotherapy Strategy Brings Greater Benefits to Children with ALL

2024 CASH丨Professor RongFu : Progress in the Study of Hematological Toxicity Related to CAR-T Therapy

2024 CASH | Professor LuGui Qiu : Continuous Advances in New Drugs, The Road to Cure Multiple Myeloma is Being Realized

2024 CASH | Professor Lei Zhang : Gene Therapy Based on AAV Vector Brings Hope for Cure to Hemophilia Patients

2024 CASH丨Professor Jun Shi : Gene Therapy for β-Thalassemia Using Lentiviral Vectors

2024 CASH | Professor Jun Ma : From ASH to CASH, the Mission of Serving Patients and Strengthening Innovation Remains Unchanged

Cultivating Virtue to Advance Surgery · Upholding the Way in Clinical Excellence | Xuesong Li’s Team Completes the First Fully Intracorporeal Autologous Kidney Transplant Using a Domestic Surgical Robot

Breast Cancer Chronicle · 2025 Professor Shusen Wang: Advances in Endocrine Therapy for HR+/HER2− Advanced Breast Cancer — Approval of Inavolisib-Based Combinations and New Pathways Opened by the evERA BC Study

Breast Cancer Chronicle · 2025 Professor Jin Yang: Breakthroughs from the ASCENT and TROPION Programs Signal the Dawn of Precision Therapy for Advanced Triple-Negative Breast Cancer

Latest Research from Academician Binghe Xu’s Team: Anucleate Red Blood Cells Act as Tumor DNA “Reservoirs,” with Apoptotic Bodies Identified as the Key Couriers

Welcome to Mediamedic 👋
It’s nice to meet you.

Welcome to Mediamedic 👋It’s nice to meet you.

Welcome to Mediamedic 👋
It’s nice to meet you.